SunWay Biotech Co., Ltd.
1271
Rank in Stocks
#19408
SunWay Biotech Co., LTD. dedicates itself to specialized research and... SunWay Biotech Co., LTD. dedicates itself to specialized research and development, coupled with the production and processing of technical materials. The company's primary focus involves the creation and manufacturing of specific bioproducts, including Monascus purpureus NTU 568 and Lactobacillus paracasei subsp. paracasei NTU 101, along with related offerings. Established in 2007, the firm operates from its headquarters in Taipei, Taiwan.
Share Price
$1.79
Last synced: 2026-11-10
Market Cap
$107.34M
Change (1 day)
4.64%
Change (1 year)
-14.16%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade SunWay Biotech Co., Ltd. (1271)
Category
Consumer Defensive
EPS for SunWay Biotech Co., Ltd. (1271)
EPS as of June 2026 TTM: $0.07
According to SunWay Biotech Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.07. At the end of 2025 the company had an EPS of $0.05, a decrease compared to its 2024 EPS of $0.06.
EPS history for SunWay Biotech Co., Ltd. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.07 | 35.20% |
| 2025 | $0.05 | -10.39% |
| 2024 | $0.06 | 21.34% |
| 2023 | $0.05 | 1.23% |
| 2022 | $0.05 | -73.16% |
| 2021 | $0.18 | 26.55% |
| 2020 | $0.14 | 248.18% |
| 2019 | $0.04 | -391.49% |
| 2018 | $-0.01 | -81.57% |
| 2017 | $-0.08 | 18.24% |
| 2016 | $-0.06 | -11.25% |
| 2015 | $-0.07 | -30.97% |
| 2014 | $-0.11 | -12.87% |
| 2013 | $-0.12 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.49 | 5,060.80% |
CH
|
|
| $3.40 | 4,931.36% |
FR
|
|
| $2.37 | 3,405.92% |
BR
|
|
| $0.24 | 248.37% |
CN
|
|
| $0.18 | 168.49% |
CN
|
Questions about SunWay Biotech Co., Ltd.'s earnings per share (EPS)
What is SunWay Biotech Co., Ltd.'s earnings per share (EPS)?
SunWay Biotech Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.07, as of Jun 2026.
What was SunWay Biotech Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, SunWay Biotech Co., Ltd.'s earnings per share (EPS) was $0.05, 16.67% less than in 2024 ($0.06).
How has SunWay Biotech Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, SunWay Biotech Co., Ltd.'s earnings per share (EPS) went from $0.14 to $0.05, an average decline of 18.61% a year.
How does SunWay Biotech Co., Ltd.'s earnings per share (EPS) compare with similar companies?
SunWay Biotech Co., Ltd.'s earnings per share (EPS) ($0.07) is lower than that of all 5 similar companies listed above. The highest among them is Nestlé S.A., with $3.49.